|

Smart Boot Use to Measure Offloading Adherence

RECRUITINGPhase 2Sponsored by University of Southern California
Actively Recruiting
PhasePhase 2
SponsorUniversity of Southern California
Started2021-10-19
Est. completion2026-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations4 sites

Summary

The purpose of this study is to help people with diabetes who develop neuropathic diabetic foot ulcers (DFUs). These ulcers, or sores, if left untreated can increase the chance of amputation. Part of the treatment is to have the person wear a diabetic shoe or boot to help their foot heal. Sometimes people don't wear the boot like they are told. The investigators want to compare three different kinds of diabetic boots to see if they can help make it easier for people to wear their boots as instructed. The investigators will look at three groups of participants: the first group will use removable offloading with reinforced education emphasizing continuous wear, including during rest and sleep, and not to remove it at any time. The second group will use removable offloading consistent with standard of care and receive education on recommended wear during walking or standing, with permission to remove the device during rest and sleep. The third group will use a smart removable offloading device that provides real-time adherence feedback via a smartwatch and smartphone, with additional personalized education informed by remotely monitored adherence data. The investigators will also be looking at how much physical activity, like walking, the participants do. And they will compare how well participants sleep and rate their quality of life in the three different boots. The investigators think that giving participants information about how much they are wearing their boot using readily available technology will help them to follow the doctor's directions better, and help their wounds heal faster.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male or female
* ≥18 years old
* Non-infected, non-ischemic DFU requiring offloading
* Ambulatory at home with or without assistance
* Willing and able to provide written informed consent

Exclusion Criteria:

* Wound present for \> 1 year
* HbA1c \> 12%
* ABI of index limb \< 0.6 or non-detectable Doppler, and/or patient being considered for revascularization during the course of the study
* Acute Charcot neuropathy or a major foot deformity that doesn't allow them to wear the smart boot
* Amputation proximal to the rearfoot on the affected extremity
* Any clinically significant medical or psychiatric condition
* Laboratory abnormality that would interfere with the ability to participate in the study
* Concurrently participating in exercise training
* Changes in psychotropic or sleep medication in the last 6 weeks
* Ulcer involves bone
* Ulcer not of diabetic origin
* Unable or unwilling to attend prescribed clinic visits or comply with protocol

Conditions2

DiabetesDiabetic Foot Ulcer

Locations4 sites

Rancho Los Amigos National Rehabilitation Center
Downey, California, 90242
Fabiola Rodriguez, MD3235162332fabiola.rodriguez@med.usc.edu
Verdugo Hills Hospital of USC
Glendale, California, 91208
Fabiola Rodriguez3235162332fabiola.rodriguez@med.usc.edu
Clemente Clinical Research
Los Angeles, California, 90033
Scott Mathis3233304287scott.mathis@clementeclinical.com
Keck Medical Center of USC
Los Angeles, California, 90033
Fabiola A Rodriguez, MD3235162332fabiola.rodriguez@med.usc.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.